Cargando…
Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer
In recent years, important clinical trials for gastric cancer (GC) and esophagogastric junction cancer (EGJC) have been reported, changing the strategies of surgical and perioperative treatment. Although laparoscopic gastrectomy has already been shown to be effective for early‐stage cancer, recent e...
Autores principales: | Yanagimoto, Yoshitomo, Kurokawa, Yukinori, Doki, Yuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472390/ https://www.ncbi.nlm.nih.gov/pubmed/37663969 http://dx.doi.org/10.1002/ags3.12711 |
Ejemplares similares
-
Surgical Treatment of Gastroesophageal Junction Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018) -
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma
por: Kurokawa, Yukinori, et al.
Publicado: (2022) -
Update on the Treatment of Gastric Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018) -
Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma
por: Yasuda, Satoshi, et al.
Publicado: (2023) -
Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma
por: Kawano, Fumihiro, et al.
Publicado: (2023)